CBNK SHAREHOLDER ALERT: ADEMI LLP INVESTIGATES WHETHER BUYOUT FAIRLY VALUES CAPITAL BANCORP, INC.
CBNK SHAREHOLDER ALERT: ADEMI LLP INVESTIGATES WHETHER BUYOUT FAIRLY VALUES CAPITAL BANCORP, INC.
PR Newswire
MILWAUKEE, Sept. 30, 2026
Capital shareholders will receive the stock equivalent of approximately $43.75 per share in an all-stock transaction valued at approximately $728.1 million; Ademi LLP is investigating the deal price, benefits to company insiders, and restrictions on competing offers
CLICK HERE TO JOIN
MILWAUKEE, Sept. 30, 2026 /PRNewswire/ -- Ademi LLP is investigating whether the proposed acquisition of Capital (NASDAQ: CBNK) by Peoples Bancorp, provides fair value to Capital's public shareholders and whether Capital's Board adequately protected shareholder interests in negotiating and approving the transaction.
Are You a Capital Shareholder?
If you own Capital shares, Ademi LLP would like to hear from you about the proposed acquisition and your rights as a shareholder.
You may also contact Guri Ademi at gademi@ademilaw.com or toll-free at 866-264-3995.
There is no cost or obligation to you.
What Is Ademi LLP Investigating?
The exchange ratio and whether it adequately reflects Capital's value and future prospects;
Substantial change-of-control benefits available to Capital insiders in connection with the transaction;
Restrictions on competing transactions, including a significant termination penalty that may discourage another potential buyer from making a superior proposal; and
The conduct of Capital's Board of Directors in negotiating and approving the transaction and whether the Board fulfilled its duties to public shareholders.
What Should Capital Shareholders Do?
Contact Ademi LLP to discuss your rights and our investigation. There is no cost or obligation to you.
Guri AdemiAdemi LLP
Toll Free: (866) 264-3995
Email: gademi@ademilaw.com
About Ademi LLP
Ademi LLP represents investors in shareholder litigation involving mergers, acquisitions, buyouts, and individual shareholder rights.
Attorney advertising. Prior results do not guarantee similar outcomes.
SOURCE Ademi LLP
The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and is not endorsed, reviewed, or verified by Morningstar.
Morningstar makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of any third-party content displayed on this site. The views and opinions expressed in third-party content are those of the respective authors and do not necessarily reflect the views of Morningstar, its affiliates, or employees.
Morningstar is not responsible for any errors, omissions, or delays in this content, nor for any actions taken in reliance thereon. Users are advised to exercise their own judgment and seek independent financial advice before making any decisions based on such content. The third-party providers of this content are not affiliated with Morningstar, and their inclusion on this site does not imply any form of partnership, agency, or endorsement.
Popular
4 Stocks to Buy Before They Rise Further
2 Undervalued Stocks to Buy Before They Rebound
The 10 Best Companies to Invest in Now
The 10 Best Dividend Stocks
United States